Joe Kiani

From Wikipedia, the free encyclopedia
Joe Kiani
Joe Kiani 2.jpg
Kiani in 2008
Born
Massi Kiani

(1964-09-16) September 16, 1964 (age 56)
Shiraz, Iran
NationalityUnited States
OccupationBusinessman
EmployerMasimo
TitleFounder of Masimo
Spouse(s)Sarah Kiani

Massi Joe E. Kiani (born September 16, 1964) is an Iranian-born American entrepreneur who founded medical technology company Masimo in 1989.

Early life[]

Joe Kiani was born in Shiraz, Iran, and immigrated to the United States at the age of nine.[1] Kiani's father was an engineer and his mother was a nurse.[2] Despite not speaking more than three words in English when he arrived in the United States, he graduated from high school at the age of 15 and, by the time he was 22, had earned both his bachelor's (B.S.E.E) and master's (M.S.E.E) degrees in electrical engineering from San Diego State University.[3] SDSU later honored Kiani with the College of Engineering's 2005 Monty Award, recognizing his achievements and success.[4]

Career at Masimo[]

Kiani founded the medical technology company Masimo in 1989 and was later joined by partner Mohammed Diab.[3] The company is now publicly traded and employs more than 5,300 people worldwide.[5] Kiani is listed as inventor on more than 500 patents or patent applications for advanced signal processing, optical sensors, and wearable technologies. Masimo pulse oximetry is used to monitor over 200 million patients per year[6] and is the primary pulse oximetry at 9 of the top 10 hospitals listed in the 2020-21 U.S. News & World Report Best Hospitals Honor Roll.[7] In 2011, Forbes named Masimo to its list of top 20 public companies under a billion dollars in revenue, based on earnings growth, sales growth, and return on equity.[8]

Pulse oximetry is one of the most commonly used monitoring technologies in healthcare. Masimo makes a pulse oximetry technology known as Signal Extraction Technology (SET), which is known as being the first pulse oximemtry technology to reliably measure-through motion and low perfusion conditions.[9][10]

Since its introduction in 1995, Masimo SET pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies, providing clinicians with increased sensitivity and specificity to help them make critical patient care decisions.[11] Masimo SET has been shown to help clinicians reduce severe retinopathy of prematurity (ROP)[12] in neonates and improve critical congenital heart disease (CCHD) screening in newborns.[13] To date, ten published CCHD screening studies, all with positive conclusions and representing over 300,000 infants, including the largest CCHD study to date, have used Masimo SET.[14] In addition, when used for continuous monitoring with a patient surveillance system, Masimo SET has been shown to reduce rapid response team activations, ICU transfers, and costs.[15]

Industry reform[]

In 2002, Kiani was interviewed for a New York Times article titled "Medicine's Middleman" that focused on the practices of Group Purchasing Organizations (GPOs) and dominant medical suppliers.[16] The article was followed by a series of 18 additional New York Times stories on GPOs over the next two years. After the Times article appeared, The United States Senate Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights held four hearings regarding these practices, at which Kiani testified twice.[17] Kiani's efforts led media to call Masimo "the poster child for small medical device manufacturers" and observe that Kiani "almost single-handedly galvanized the rancorous debate over the GPO industry's purported role in locking out innovative technologies from the marketplace."[18]

Kiani is active in efforts to reform U.S. health care and encourage medical innovation. In 2010, Kiani and Masimo provided $10 million in funding to create the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, which is dedicated to encouraging and promoting activities that improve patient safety and deliver advanced healthcare worldwide.[19] Masimo Foundation supports third-party research, development initiatives, and clinical studies with an emphasis on transformative projects that seek to truly enhance patient safety and outcomes; helping to forge a world free of sickness, disease and inhumanity.

Philanthropic and humanitarian efforts, Honors, and Awards[]

In 2012, Kiani was named Ernst & Young National Entrepreneur of the Year, Life Sciences, for demonstrating commitment and vision in revolutionizing the health care industry through the creation and commercialization of innovative noninvasive patient monitoring technologies.[20]

Joe Kiani testifies at the U.S. Senate HELP Committee.

In 2013 Kiani founded the Patient Safety Movement Foundation through the support of the Masimo Foundation. More than 200,000 preventable patient deaths occur each year in U.S. hospitals.[21][22] The Patient Safety Movement is committed to reducing these deaths to zero by 2030. The foundation also convenes the action-oriented annual Patient Safety, Science & Technology summit. In 2020, the Patient Safety Movement Foundation was awarded a $5 million, five-year grant from the Masimo Foundation to help advance its mission and expedite its efforts.[23]

On September 24, 2013, Kiani appeared before the Senate Health, Education, Labor & Pensions Committee and laid out five steps to help eradicate preventable patient deaths. Senator Tom Harkin, D-Iowa, said the hearing was "The most important hearing this committee would hold all year."[citation needed]

Also on September 24, 2013, the Patient Safety Movement announced its Commitment to Action to reduce preventable patient deaths in U.S. hospitals to zero by 2020 at the 2013 Clinton Global Initiative (CGI) Annual Meeting in New York.[citation needed]

In March 2014, Forbes interviewed Kiani in an article called "Re-Engineering Healthcare To Eliminate Preventable Deaths".[24]

On April 1, 2014, Kiani was named by Becker's Hospital Review as one of "50 Experts Leading the Field of Patient Safety".[25] Kiani was the only patient safety expert named who is also a medical technology company CEO. Kiani has subsequently been recognized on the same list of top 50 patient safety experts in 2015, 2016, and 2017.

In 2016, Kiani was asked by then-Vice President Joe Biden to put together a team of cancer researchers and experts to assist in the “Cancer Moonshot” initiative first announced by President Obama during the January 2016 State of the Union address, with the goal of speeding cancer treatments and ultimately eradicating cancer.

In 2017, at its 5th annual summit, the Patient Safety Movement Foundation announced that almost 70,000 lives had been saved and over 69 healthcare technology companies had pledged to share their data, helping to create an ecosystem for engineers to develop predictive algorithms that can help save even more lives.

In 2017, Kiani was awarded an Honorary Doctorate of Science by Chapman University.[26] In addition, Kiani and his wife Sarah Kiani were honored by the Anti-Defamation League (ADL) with the Humanitarian Award for professional and philanthropic excellence [1].

In 2018, the Intellectual Property Owners Education Foundation (IPOEF) honored Kiani with the first IP Champion Award, for "extraordinary leadership in advocating for the value of intellectual property to the progress of innovation."[27]

In 2019, Kiani was made an honorary member of the Mexican Academy of Surgery.[28] He also began serving on the Advisory Board of the University of California at Irvine (UCI) Susan and Henry Samueli College of Health Sciences [2].

In 2020, Kiani was honored by the Ibero-American Society of Neonatology (SIBEN) with the Award for Improvement of Neonatal Health in Latin America.[29] He was also a recipient of a City of Hope Humanitarian Award, though the “Let’s Be Frank About Cancer” presentation gala was postponed due to the pandemic [3].

In 2020, Kiani joined Chris Evans and Mark Kassen in creating A Starting Point, a video-based civic engagement platform whose mission is to create a bipartisan channel of communication and connectivity between Americans and their elected officials, with the goal of creating a more informed electorate.[30]

In 2021, Kiani was awarded an honorary Doctor of Science degree from San Diego State University (SDSU), originally due to be conferred in 2020 but delayed by the pandemic [4]. He also became a member of the Wall Street Journal’s CEO Council [5] and began serving as a member of the Board of Trustees of the California Institute of Technology (Caltech) [6], the Board of Councilors of the Carter Center, and the Chair of the Board Quality Committee of the Children’s Hospital of Orange County (CHOC) [7].

References[]

  1. ^ "Masimo Ceo Joe Kiani Part 1".
  2. ^ "Masimo Ceo Joe Kiani Interview Part 3".
  3. ^ Jump up to: a b Reed, Vita (26 March 2006). "Masimo's Kiani: Stared Down Tyco". AllBusiness. Archived from the original on 16 April 2009.
  4. ^ "Distinguished Alumni". electrical.sdsu.edu. Retrieved 2020-06-03.
  5. ^ "Masimo Corporation". Anesthesiology News. Retrieved 2020-08-26.
  6. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2014-06-04. Retrieved 2014-04-16.CS1 maint: archived copy as title (link)
  7. ^ "U.S. News and World Report Best Hospitals Honor Roll". Archived from the original on 2016-08-03.
  8. ^ Badenhausen, Kurt (19 October 2011). "The Top 20 Small Public Companies in America". Forbes.
  9. ^ "Anesthesia & Analgesia". www.anesthesia-analgesia.org. Retrieved 2020-08-26.
  10. ^ "Masimo to Release New Halo Index, Radical 7 Pulse Oximeter, Patient SafetyNet Monitoring System |". 14 October 2010.
  11. ^ "Masimo - Clinical Evidence - SET® Pulse Oximetry". www.masimo.com. Retrieved 2021-05-07.
  12. ^ Castillo, Armando; Deulofeut, Richard; Critz, Ann; Sola, Augusto (February 2011). "Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO2 technology". Acta Paediatrica. 100 (2): 188–192. doi:10.1111/j.1651-2227.2010.02001.x. ISSN 0803-5253. PMC 3040295. PMID 20825604.
  13. ^ Granelli, Anne de-Wahl; Wennergren, Margareta; Sandberg, Kenneth; Mellander, Mats; Bejlum, Carina; Inganäs, Leif; Eriksson, Monica; Segerdahl, Niklas; Ågren, Annelie; Ekman-Joelsson, Britt-Marie; Sunnegårdh, Jan (2009-01-09). "Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns". BMJ. 338: a3037. doi:10.1136/bmj.a3037. ISSN 0959-8138. PMC 2627280. PMID 19131383.
  14. ^ "Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry". www.businesswire.com. 2021-03-22. Retrieved 2021-05-07.
  15. ^ McGrath, Susan P.; McGovern, Krystal M.; Perreard, Irina M.; Huang, Viola; Moss, Linzi B.; Blike, George T. (2020-03-14). "Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity". Journal of Patient Safety. doi:10.1097/PTS.0000000000000696. ISSN 1549-8425. PMID 32175965.
  16. ^ Walsh, Mary Williams; Meier, Barry (4 March 2002). "MEDICIne's MIDDLEMEN; Questions Raised of Conflicts at 2 Hospital Buying Groups". The New York Times.
  17. ^ "Testimony of Mr. Joe Kiani". 14 September 2004.
  18. ^ HighBeam[dead link]
  19. ^ "Masimo Foundation: Grants for Global Health". Inside Philanthropy. Retrieved 2020-08-26.
  20. ^ "Creator of Non-Invasive Patient Monitoring Devices: Masimo Corporation Founder and CEO Joe Kiani Named Ernst & Young National Entrepreneur of the Year&#0174 2012 Life Sciences Award Winner". BioSpace. Retrieved 2021-02-09.
  21. ^ Levinson, Daniel. "Adverse Events in Hospitals: National Incidence Among Medicare Beneficiaries" (PDF).
  22. ^ "Archived copy". Archived from the original on 2013-09-09. Retrieved 2012-12-08.CS1 maint: archived copy as title (link)
  23. ^ "Patient Safety Movement Foundation Awarded $5 Million to Help Advance Its Mission to Improve Patient Safety and Reduce Preventable Hospital Deaths". Patient Safety Movement. 2020-04-14. Retrieved 2020-04-20.
  24. ^ "Re-Engineering Healthcare to Eliminate Preventable Deaths".
  25. ^ "50 Experts Leading the Field of Patient Safety — 2014".
  26. ^ "Schmid College Commencement to Feature Paul Cook, Joe Kiani, Alma Clark '78, Taylor Patti '17". Schmid College of Science and Technology. Retrieved 2019-06-05.
  27. ^ "IP Champion Award". IPO Education Foundation. Retrieved 2019-06-05.
  28. ^ "Joe Kiani Named Honorary Academic by Mexican Academy of Surgery". Patient Safety Movement. 2019-06-05. Retrieved 2019-06-06.
  29. ^ "Masimo Founder and CEO and Co-Inventor of Measure-Through-Motion Pulse Oximetry, Joe Kiani, Awarded by the Ibero-American Society of Neonatology for Improvements to Neonatal Health in Latin America". www.businesswire.com. 2020-11-09. Retrieved 2020-11-16.
  30. ^ "A Starting Point". www.astartingpoint.com. Retrieved 2021-05-07.

External links[]

Retrieved from ""